Axinn Named a “Legal Lion” for Federal Circuit Patent Win
January 18, 2019
Axinn was named a “Legal Lion” in the Law360 Weekly Verdict roundup for its Federal Circuit win on behalf of Alvogen Pine Brook LLC. On January 14, 2019, the Federal Circuit upheld a lower court ruling that cleared Axinn’s client Alvogen of patent infringement. The decision affirmed Axinn’s trial court victory, in which a Delaware Federal District court ruled that Alvogen’s generic version of the colitis medication Uceris® did not infringe a patent owned by Cosmo Technologies Ltd. Alvogen was represented by Axinn partners Jason Murata, who argued the case before the Federal Circuit, and Matthew Becker, who tried the case before the Delaware District Court.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
The 32nd Annual Marketing Partner Forum
Event
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025
Client Alerts
Antitrust
Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards
Awards & Recognitions
Antitrust
Merger Remedies Back in Vogue Under Trump
Media Mentions
Antitrust
Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation
Axinn Viewpoints
Intellectual Property
A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness
Axinn Viewpoints
Intellectual Property